Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2019-02-01

Original market date: See footnote 1

2019-02-01

Product name:

AURO-QUINAPRIL HCTZ

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02473291

Product Monograph/Veterinary Labelling:

Date: 2019-07-16 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

AURO PHARMA INC
3700 Steeles Avenue West, Suite 402
Woodbridge
Ontario
Canada  L4L 8K8

Class: 

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

2

Schedule(s):

Prescription  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

40:28.20   THIAZIDE DIURETICS ,  24:32.04   ANGIOTENSIN-CONVERTING ENZYME INHIBITORS

Anatomical Therapeutic Chemical (ATC): See footnote 4

C09BA06  QUINAPRIL AND DIURETICS

Active ingredient group (AIG) number:See footnote 5

0231789001

List of active ingredient(s)
Active ingredient(s) Strength
HYDROCHLOROTHIAZIDE 12.5 MG
QUINAPRIL (QUINAPRIL HYDROCHLORIDE) 10 MG

Application information

Related information

Contact us

Version 3.8.0
Date modified: